Payment overview · 2025
General Payments
$293.67
10 reported records · 3 companies
Healthcare provider profile · identity verified
Stephen A Rubendall, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CAMILLA, GA · NPI 1851345284
Verified facts
What the public records show
CMS Open Payments records show Stephen A Rubendall, M.D. received $293.67 in general payments during 2025 across 10 reported records.
GlaxoSmithKline, LLC. accounted for 47.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 85 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $140.39 | 47.8% | 8 | 2025 |
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $132.49 | 45.1% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $20.79 | 7.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $293.67 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $140.39 | 8 | 2025 |
Source payment records
|
|||||
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $132.49 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $20.79 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 85 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
29 | 29 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
12 | 11 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
85 | 24 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1628 | 344 |
| Amlodipine Besylate | Amlodipine Besylate | 722 | 184 |
| Potassium Chloride | Potassium Chloride | 710 | 179 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 606 | 154 |
| Gabapentin | Gabapentin | 565 | 122 |
| Levothyroxine Sodium | Levothyroxine Sodium | 561 | 125 |
| Losartan Potassium | Losartan Potassium | 495 | 122 |
| Pantoprazole Sodium | Pantoprazole Sodium | 449 | 99 |
| Metformin Hcl | Metformin Hcl | 413 | 97 |
| Lisinopril | Lisinopril | 412 | 98 |
| Furosemide | Furosemide | 398 | 91 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 395 | 129 |
| Tamsulosin Hcl | Tamsulosin Hcl | 380 | 80 |
| Jardiance | Empagliflozin | 376 | 65 |
| Eliquis | Apixaban | 363 | 55 |
| Omeprazole | Omeprazole | 361 | 82 |
| Metoprolol Succinate | Metoprolol Succinate | 332 | 73 |
| Chlorthalidone | Chlorthalidone | 323 | 77 |
| Famotidine | Famotidine | 311 | 77 |
| Carvedilol | Carvedilol | 287 | 66 |
| Allopurinol | Allopurinol | 272 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 267 | 47 |
| Hydralazine Hcl | Hydralazine Hcl | 227 | 53 |
| Donepezil Hcl | Donepezil Hcl | 219 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 217 | 60 |
| Trazodone Hcl | Trazodone Hcl | 210 | 50 |
| Montelukast Sodium | Montelukast Sodium | 200 | 49 |
| Spironolactone | Spironolactone | 198 | 46 |
| Mirtazapine | Mirtazapine | 197 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 190 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 188 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 185 | 74 |
| Prednisone | Prednisone | 183 | 125 |
| Zolpidem Tartrate | Zolpidem Tartrate | 180 | 29 |
| Levetiracetam | Levetiracetam | 177 | 19 |
| Alprazolam | Alprazolam | 160 | 40 |
| Nifedipine Er | Nifedipine | 159 | 30 |
| Pregabalin | Pregabalin | 159 | 47 |
| Amiodarone Hcl | Amiodarone Hcl | 157 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 146 | 59 |
| Farxiga | Dapagliflozin Propanediol | 145 | 23 |
| Bumetanide | Bumetanide | 140 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 135 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 133 | 22 |
| Mounjaro | Tirzepatide | 127 | 29 |
| Atenolol | Atenolol | 126 | 26 |
| Sertraline Hcl | Sertraline Hcl | 126 | 32 |
| Tramadol Hcl | Tramadol Hcl | 125 | 39 |
| Memantine Hcl | Memantine Hcl | 123 | 23 |
| Entresto | Sacubitril/Valsartan | 118 | 17 |
| Linzess | Linaclotide | 115 | 33 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 112 | 25 |
| Lorazepam | Lorazepam | 102 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 101 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 98 | 14 |
| Valsartan | Valsartan | 97 | 25 |
| Alendronate Sodium | Alendronate Sodium | 94 | 26 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 91 | 52 |
| Ozempic | Semaglutide | 90 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 89 | 21 |
| Clonidine Hcl | Clonidine Hcl | 85 | 25 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 85 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 85 | 24 |
| Clonazepam | Clonazepam | 84 | 17 |
| Fentanyl | Fentanyl | 79 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 79 | 20 |
| Glipizide | Glipizide | 78 | 24 |
| Ezetimibe | Ezetimibe | 77 | 29 |
| Glipizide Er | Glipizide | 77 | 16 |
| Risperidone | Risperidone | 75 | 12 |
| Lactulose | Lactulose | 74 | 30 |
| Amitriptyline Hcl | Amitriptyline Hcl | 73 | 15 |
| Januvia | Sitagliptin Phosphate | 73 | 13 |
| Torsemide | Torsemide | 72 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 69 | 37 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 21 |
| Finasteride | Finasteride | 65 | suppressed |
| Myrbetriq | Mirabegron | 64 | 12 |
| Simvastatin | Simvastatin | 64 | 17 |
| Levemir | Insulin Detemir | 62 | 15 |
| Sucralfate | Sucralfate | 61 | 11 |
| Baclofen | Baclofen | 59 | 14 |
| Xarelto | Rivaroxaban | 58 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 57 | 27 |
| Pioglitazone Hcl | Pioglitazone Hcl | 57 | 16 |
| Buspirone Hcl | Buspirone Hcl | 55 | 12 |
| Estradiol | Estradiol | 54 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 53 | 12 |
| Restasis | Cyclosporine | 52 | suppressed |
| Topiramate | Topiramate | 50 | suppressed |
| Trulicity | Dulaglutide | 50 | 19 |
| Lubiprostone | Lubiprostone | 49 | 16 |
| Constulose | Lactulose | 48 | 18 |
| Diltiazem Hcl | Diltiazem Hcl | 48 | suppressed |
| Azithromycin | Azithromycin | 46 | 24 |
| Bupropion Xl | Bupropion Hcl | 46 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 46 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 46 | 22 |
| Ropinirole Hcl | Ropinirole Hcl | 46 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 44 | 40 |
| Meclizine Hcl | Meclizine Hcl | 44 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 13 |
| Meloxicam | Meloxicam | 42 | 15 |
| Ranolazine Er | Ranolazine | 41 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 20 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 38 | suppressed |
| Novolin R | Insulin Regular, Human | 38 | suppressed |
| Ketoconazole | Ketoconazole | 37 | 24 |
| Levemir Flexpen | Insulin Detemir | 37 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 37 | 12 |
| Divalproex Sodium | Divalproex Sodium | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 35 | suppressed |
| Fluconazole | Fluconazole | 35 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | suppressed |
| Naproxen | Naproxen | 34 | 20 |
| Novolog | Insulin Aspart | 34 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 33 | 16 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 33 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Humalog | Insulin Lispro | 32 | suppressed |
| Ondansetron Odt | Ondansetron | 32 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 32 | 12 |
| Cefuroxime | Cefuroxime Axetil | 31 | 27 |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 25 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 30 | suppressed |
| Levofloxacin | Levofloxacin | 30 | 28 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 29 | 29 |
| Lovastatin | Lovastatin | 29 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 27 | suppressed |
| Telmisartan | Telmisartan | 27 | suppressed |
| Mupirocin | Mupirocin | 26 | 21 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 25 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 25 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 23 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 23 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 22 | 20 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 12 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 21 | 20 |
| Colchicine | Colchicine | 21 | suppressed |
| Desloratadine | Desloratadine | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 21 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Glimepiride | Glimepiride | 20 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Diazepam | Diazepam | 19 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 19 | suppressed |
| Indapamide | Indapamide | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Scopolamine | Scopolamine | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 18 | suppressed |
| Belsomra | Suvorexant | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 18 | suppressed |
| Minoxidil | Minoxidil | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | suppressed |
| Humulin R | Insulin Regular, Human | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Phenytoin | Phenytoin | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Carisoprodol | Carisoprodol | 16 | suppressed |
| Clotrimazole | Clotrimazole | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Cefdinir | Cefdinir | 15 | 15 |
| Desmopressin Acetate | Desmopressin Acetate | 15 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 15 |
| Praluent Pen | Alirocumab | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Glyburide | Glyburide | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Prolia | Denosumab | 13 | 11 |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Acarbose | Acarbose | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 12 | 11 |
| Xtampza Er | Oxycodone Myristate | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Flunisolide | Flunisolide | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $293.67 · 10 records | GlaxoSmithKline, LLC. | Cologuard Collection Kit, Da Vinci Surgical System, TRELEGY ELLIPTA | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error